| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.57 | 0.006 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |